Harvard University Expert to Host Scleroderma Webinar: New Directions for Scleroderma Treatments: Understanding the Basis for Current Clinical Trials on December 14, 2012
A Free Service Provided for Patients and Caregivers by the Scleroderma Research Foundation with support from Gilead Sciences, MedImmune and Novartis Where:
Register online at www.sclerodermaRESEARCH.org .
Research and Markets: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2012Published: December 3, 2012
Global Markets Direct's, 'Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Systemic Sclerosis (Scleroderma), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Systemic Sclerosis (Scleroderma).
To purchase or read more: http://www.heraldonline.com/2012/12/03/4455191/research-and-markets-systemic.html#storylink=cpy